Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey

The efficacy of albendazole for the treatment of giardiasis has been indicated by previous in-vitro and in-vivo studies. In order to compare the therapeutic efficacy of albendazole and metronidazole, 107 Giardia-positive children (aged 3–15 years), diagnosed by three consecutive positive stool exami...

Full description

Saved in:
Bibliographic Details
Published inClinical microbiology and infection Vol. 10; no. 6; pp. 527 - 529
Main Authors Yereli, K., Balcioğlu, İ.C., Ertan, P., Limoncu, E., Onağ, A.
Format Journal Article
LanguageEnglish
Published Oxford, UK Elsevier Ltd 01.06.2004
Blackwell Science Ltd
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The efficacy of albendazole for the treatment of giardiasis has been indicated by previous in-vitro and in-vivo studies. In order to compare the therapeutic efficacy of albendazole and metronidazole, 107 Giardia-positive children (aged 3–15 years), diagnosed by three consecutive positive stool examinations, were enrolled in the study. Of these children, 52 were given a single daily dose of albendazole 10 mg/kg for 5 days, and 55 were given metronidazole 20 mg/kg daily in three doses for 7 days. Parasite eradication was achieved in 47 (90.4%) of 52 children treated with albendazole and 49 (89.1%) of 55 children treated with metronidazole (p > 0.05). These results suggest that albendazole is an effective treatment option for childhood giardiasis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-News-3
ISSN:1198-743X
1469-0691
DOI:10.1111/j.1198-743X.2004.00829.x